Novo Nordisks onceweekly injectable, Ozempic (semaglutide), originally developed for type 2 diabetes, has increasingly attracted attention in Egypt, not just for its blood-sugar-lowering benefits, but for its marked weightloss effect too
In doing so, it is also very effective for weight loss and can help reduce the cardiovascular risk factors that come from overweight and diabetes like hypertension, coronary artery disease and hypercholesterolemia
Wegovy (Semaglutide Injection) Wegovy contains the same active ingredient, semaglutide, as found in Ozempic
Rob Berberian and his comprehensive approach to regenerative medicine
Book your consultation or complete your intake form to begin
[Abstract]2025 Nov 17:29:0246